Oh, and have a good Christmas all. Look forward to a rapid run to positive cash flows in 2024, that OCC would already be enjoying were it not for it's R&D expenditure, which is of course mainly getting Remplir and ATI to market in the US. An investment of capital and cash flows that none of us would disagree with.
l
Ann: Orthocell Board Change, page-4
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.8¢ |
Change
0.003(0.65%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.0¢ | 38.5¢ | $8.478K | 21.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3934 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 13538 | 2 |
View Market Depth
| Last trade - 10.47am 29/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |